BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Immutep S.A. 

Parc Club Orsay, 2, Rue Jean

Rostand  Orsay  92296  France
Phone: n/a Fax:


SEARCH JOBS





Segment
Start Up





 Company News
Immutep S.A. And Eddingpharm (Cayman) Inc. Start Production Of Immufact® IMP321 At WuXi AppTec, Inc. In China 4/8/2014 1:36:01 PM    More...
Immutep S.A. and Eddingpharm (Cayman) Inc. Sign Agreement for Development of ImmuFact® IMP321 in China 10/7/2013 9:25:53 AM    More...
Immutep S.A. and Lonza Inc. Sign Agreement for Cell Line Selection, Cell Banking and Process Development of ImmuFact(R) IMP321 4/10/2012 11:23:20 AM    More...
Immutep S.A. and GlaxoSmithKline (GSK) Sign Licence Agreement for IMP731, a Novel Therapeutic Antibody for the Treatment of Autoimmune Diseases 1/6/2011 11:09:35 AM    More...
Immutep S.A. Announces Final Results in Phase I/II Chemoimmunotherapy Trial in Metastatic Breast Cancer 9/7/2010 1:54:45 PM    More...
Immutep S.A. Announces Oral Presentation At American Society of Clinical Oncology Annual Meeting Of IMP321 Final Results In Phase I/II Chemoimmunotherapy Trial 5/19/2010 10:59:14 AM    More...
Immutep S.A. Announces Final Results In Phase I/II Chemoimmunotherapy Trial In Breast Cancer 1/4/2010 10:52:45 AM    More...
Immutep S.A. Announces New Interim Results In Phase I/II Chemoimmunotherapy Trial In Breast Cancer 10/6/2009 2:05:45 PM    More...
Immutep S.A. Announces Final Results In Advanced Renal Cell Carcinoma 9/29/2009 1:20:24 PM    More...
Immutep S.A. Announces Start of Clinical Trial in Pancreatic Cancer 4/15/2009 11:44:11 AM    More...
12